BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29778368)

  • 1. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?
    Griesinger G; Blockeel C; Tournaye H
    Fertil Steril; 2018 May; 109(5):756-762. PubMed ID: 29778368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
    Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
    Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.
    Saharkhiz N; Zamaniyan M; Salehpour S; Zadehmodarres S; Hoseini S; Cheraghi L; Seif S; Baheiraei N
    Gynecol Endocrinol; 2016; 32(3):213-7. PubMed ID: 26486011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis.
    Griesinger G; Blockeel C; Kahler E; Pexman-Fieth C; Olofsson JI; Driessen S; Tournaye H
    PLoS One; 2020; 15(11):e0241044. PubMed ID: 33147288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study.
    Vuong LN; Pham TD; Le KTQ; Ly TT; Le HL; Nguyen DTN; Ho VNA; Dang VQ; Phung TH; Norman RJ; Mol BW; Ho TM
    Hum Reprod; 2021 Jun; 36(7):1821-1831. PubMed ID: 33930124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase III randomized controlled trial of oral dydrogesterone versus intravaginal progesterone gel for luteal phase support in
    Yang DZ; Griesinger G; Wang W; Gong F; Liang X; Zhang H; Sun Y; Kahler E; Pexman-Fieth C; Olofsson JI; Tournaye H; Chen ZJ
    Gynecol Endocrinol; 2020 Feb; 36(2):175-183. PubMed ID: 31397179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
    Chakravarty BN; Shirazee HH; Dam P; Goswami SK; Chatterjee R; Ghosh S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Dydrogesterone for Luteal Phase Support in Assisted Reproduction.
    Patki A
    Reprod Sci; 2024 Jan; 31(1):17-29. PubMed ID: 37488405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
    Netter A; Mancini J; Buffat C; Agostini A; Perrin J; Courbiere B
    PLoS One; 2019; 14(7):e0220450. PubMed ID: 31361764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.
    Nadarajah R; Rajesh H; Wong KY; Faisal F; Yu SL
    Singapore Med J; 2017 Jun; 58(6):294-297. PubMed ID: 27090598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of oral dydrogesterone and vaginal micronized progesterone for luteal phase support in intrauterine insemination.
    Taş M; Uludag SZ; Aygen ME; Sahin Y
    Gynecol Endocrinol; 2020 Jan; 36(1):77-80. PubMed ID: 31464143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials.
    Barbosa MW; Silva LR; Navarro PA; Ferriani RA; Nastri CO; Martins WP
    Ultrasound Obstet Gynecol; 2016 Aug; 48(2):161-70. PubMed ID: 26577241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients.
    Ozer G; Yuksel B; Yucel Cicek OS; Kahraman S
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102030. PubMed ID: 33271319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.
    Ganesh A; Chakravorty N; Mukherjee R; Goswami S; Chaudhury K; Chakravarty B
    Fertil Steril; 2011 May; 95(6):1961-5. PubMed ID: 21333984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial.
    Zarei A; Sohail P; Parsanezhad ME; Alborzi S; Samsami A; Azizi M
    Arch Gynecol Obstet; 2017 Jan; 295(1):239-246. PubMed ID: 27761732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable Outcomes Using Oral Dydrogesterone Vs. Micronized Vaginal Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study.
    Atzmon Y; Aslih N; Estrada D; Bilgory A; Ellenbogen A; Shalom-Paz E
    Reprod Sci; 2021 Jul; 28(7):1874-1881. PubMed ID: 33140324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis.
    Barbosa MWP; Valadares NPB; Barbosa ACP; Amaral AS; Iglesias JR; Nastri CO; Martins WP; Nakagawa HM
    JBRA Assist Reprod; 2018 Jun; 22(2):148-156. PubMed ID: 29488367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised control trial on oral dydrogesterone
    Ikechebelu JI; Dim CC; Eleje GU; Joe-Ikechebelu N; Okpala BC; Okam PC
    J Med Life; 2023 Jan; 16(1):62-69. PubMed ID: 36873122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.